Artikel
Lizenziert
Nicht lizenziert
Erfordert eine Authentifizierung
Quantification of human serum insulin concentrations in clinical pharmacokinetic or bioequivalence studies: what defines the “best method”?
-
James P. Cassidy
,
Stephen D. Luzio
Veröffentlicht/Copyright:
19. Januar 2012
Abstract
Background: Historically, quantitative clinical diagnostic assays (QCDAs) have not been accepted for use in pharmacokinetic or bioequivalence studies because they do not fully comply with the US Food and Drug Administration (FDA) Guidance for Industry: Bioanalytical Method Validation (e.g., full calibration curve not generated with each analytical run). Samples from a bioequivalence study were analysed for insulin and C-peptide concentrations with QCDAs and guidance-conforming radioimmunoassays (RIAs) and the results compared across and within assays.
Methods: Serum samples (n=1913) from study MKC-TI-142 were analysed first using the Roche E170 electrochemiluminescence immunoassay (ECLIA) for insulin concentration and the Immulite 2000 chemiluminescence immunoassay (CLIA) for C-peptide, and then using the corresponding Millipore RIAs.
Results: The insulin assays were highly correlated: r2=0.92 excluding samples requiring dilution and R2=0.88 including all samples. There was increasing negative bias of the ECLIA compared with the RIA with increasing insulin, especially with samples that required dilution for the RIA. The ECLIA had significantly fewer below-quantifiable-limit samples, a larger dynamic analysis range without dilution, and tighter agreement within incurred sample reanalysis (ISR) as compared with the RIA. The C-peptide assays showed good agreement but the CLIA method produced ISR results that were in closer agreement with the original values.
Conclusions: The science indicates that the QCDAs are appropriate for the quantification of serum insulin (ECLIA) and C-peptide (CLIA) concentrations in human pharmacokinetic and bioequivalence studies even though the calibration curve is not generated in each analytical run.
Keywords: bioequivalence; chemiluminescence immunoassay; electrochemiluminescence immunoassay; human serum insulin; pharmacokinetics; radioimmunoassay C-peptide
Received: 2011-6-8
Accepted: 2011-11-22
Published Online: 2012-01-19
Published in Print: 2012-04-01
©2012 by Walter de Gruyter Berlin Boston
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Artikel in diesem Heft
- A sensitive quantitative test strip based point-of-care albuminuria screening assay
- Editorials
- Serum biomarkers for the non-invasive diagnosis of liver fibrosis: the importance of being validated
- Primary blood tubes mixing: time for updated recommendations
- Reviews
- 10.1515/cclm-2011-0847
- The hCG assay or pregnancy test
- Mini Reviews
- The role of mean platelet volume in predicting thrombotic events
- The role of red blood cell distribution width in cardiovascular and thrombotic disorders
- Genetics and Molecular Diagnostics
- Comparison of different collection procedures and two methods for DNA isolation from saliva
- Detection of α-globin gene deletion and duplication using quantitative multiplex PCR of short fluorescent fragments
- High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR
- General Clinical Chemistry and Laboratory Medicine
- Quantification of human serum insulin concentrations in clinical pharmacokinetic or bioequivalence studies: what defines the “best method”?
- Serum cystatin C is an early biomarker for assessment of renal function in burn patients
- 10.1515/cclm.2011.0849
- Mid-stream vs. first-voided urine collection by using automated analyzers for particle examination in healthy subjects: an Italian multicenter study
- Percentage of hypochromic erythrocytes as a potential marker of iron availability
- Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay
- Validation and Outcome Studies
- Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C
- Cancer Diagnostics
- Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients
- Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer
- Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients
- Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers
- Cardiovascular Diseases
- The performance of high sensitivity troponin for the diagnosis of acute myocardial infarction is underestimated
- The prognostic value of N-terminal pro-brain natriuretic peptide in non-ST elevation acute coronary syndromes: a meta-analysis
- Measurement of high-molecular-weight adiponectin is not useful in assessing coronary stenosis
- Letters to the Editor
- Serum concentration of neopterin on admission does not improve the diagnostic performance of highly-sensitive troponin I
- Evaluation of the interference by homogentisic acid and other organic acids on the enzymatic and Jaffé method creatinine assay
- A comparative analysis of the Iris iQ200 with manual microscopy as a diagnostic tool for dysmorphic erythrocytes in urine
- Falsely decreased ionized calcium results due to analytical interference by teriflunomide, the active metabolite of leflunomide (Arava®)
- Is polyethylene glycol precipitation of hyperprolactinaemic samples required when using the Beckman Coulter DxI-800 prolactin assay?
- Congress Abstracts
- ISMD2012: Ninth International Symposium on Molecular Diagnostics
- ArabMedLab Marrakech 2012
- Masthead
- Masthead
Schlagwörter für diesen Artikel
bioequivalence;
chemiluminescence immunoassay;
electrochemiluminescence immunoassay;
human serum insulin;
pharmacokinetics;
radioimmunoassay C-peptide
Artikel in diesem Heft
- A sensitive quantitative test strip based point-of-care albuminuria screening assay
- Editorials
- Serum biomarkers for the non-invasive diagnosis of liver fibrosis: the importance of being validated
- Primary blood tubes mixing: time for updated recommendations
- Reviews
- 10.1515/cclm-2011-0847
- The hCG assay or pregnancy test
- Mini Reviews
- The role of mean platelet volume in predicting thrombotic events
- The role of red blood cell distribution width in cardiovascular and thrombotic disorders
- Genetics and Molecular Diagnostics
- Comparison of different collection procedures and two methods for DNA isolation from saliva
- Detection of α-globin gene deletion and duplication using quantitative multiplex PCR of short fluorescent fragments
- High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR
- General Clinical Chemistry and Laboratory Medicine
- Quantification of human serum insulin concentrations in clinical pharmacokinetic or bioequivalence studies: what defines the “best method”?
- Serum cystatin C is an early biomarker for assessment of renal function in burn patients
- 10.1515/cclm.2011.0849
- Mid-stream vs. first-voided urine collection by using automated analyzers for particle examination in healthy subjects: an Italian multicenter study
- Percentage of hypochromic erythrocytes as a potential marker of iron availability
- Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay
- Validation and Outcome Studies
- Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C
- Cancer Diagnostics
- Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients
- Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer
- Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients
- Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers
- Cardiovascular Diseases
- The performance of high sensitivity troponin for the diagnosis of acute myocardial infarction is underestimated
- The prognostic value of N-terminal pro-brain natriuretic peptide in non-ST elevation acute coronary syndromes: a meta-analysis
- Measurement of high-molecular-weight adiponectin is not useful in assessing coronary stenosis
- Letters to the Editor
- Serum concentration of neopterin on admission does not improve the diagnostic performance of highly-sensitive troponin I
- Evaluation of the interference by homogentisic acid and other organic acids on the enzymatic and Jaffé method creatinine assay
- A comparative analysis of the Iris iQ200 with manual microscopy as a diagnostic tool for dysmorphic erythrocytes in urine
- Falsely decreased ionized calcium results due to analytical interference by teriflunomide, the active metabolite of leflunomide (Arava®)
- Is polyethylene glycol precipitation of hyperprolactinaemic samples required when using the Beckman Coulter DxI-800 prolactin assay?
- Congress Abstracts
- ISMD2012: Ninth International Symposium on Molecular Diagnostics
- ArabMedLab Marrakech 2012
- Masthead
- Masthead
